Skip to main content
. 2020 Feb 24;9(5):e015139. doi: 10.1161/JAHA.119.015139

Figure 4.

Figure 4

Benefit associated with randomization to implantable cardioverter‐defibrillator (ICD) therapy in the SCD‐HeFT (Sudden Cardiac Death in Heart Failure Trial). Defibrillators were associated with the greatest reduction in all‐cause mortality among patients with low overall mortality risk based on the Seattle Heart Failure Model (SHFM) and high proportional sudden cardiac death risk based on the Seattle Proportional Risk Model (SPRM). CI indicates confidence interval; HR, hazard ratio. Reprinted from Levy et al38 with permission. Copyright ©2018, Elsevier.